March 2, 2022
Technological advances in imaging and drug delivery, often driven by engineers, enable us to redefine how we detect, treat and monitor cancer. The purpose of this catalyst conference is to bring together experts in these areas to highlight current state of the art in cancer detection, treatment and monitoring which will highlight opportunities for collaborations and formulate strategies for addressing critical questions in cancer detection and monitoring.
View the preliminary agenda.
Ze’ev Ronai, PhD
Director, NCI-Designated Cancer Center, and Professor, Sanford Burnham Prebys Medical Discovery Institute